OCUL 250516 10.00C(OCUL250516C10000) Stock Price Today

US OptionsDetailed Quotes

OCUL250516C10000

Watchlist

0.09
+0.01+12.50%

15min DelayClose May 2 16:00 ET

0.10High0.08Low

Intraday

5D
Daily

News

Is Ocular Therapeutix (NASDAQ:OCUL) Using Debt Sensibly?
Simply Wall StMay 1 07:35 ET
BofA Securities Maintains Ocular Therapeutix(OCUL.US) With Buy Rating
Moomoo NewsMay 1 02:34 ET · Ratings
Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL), Xencor (XNCR) and GeneDx Holdings (WGS)
TipRanksApr 30 09:23 ET · Ratings
Earnings Preview: OCUL to Report Financial Results Pre-market on May 05
Moomoo NewsApr 29 21:00 ET
Ocular Therapeutix to Participate in Upcoming Investor and Scientific Conferences
GlobeNewswireApr 29 07:00 ET
Ocular Therapeutix to Report First Quarter 2025 Financial Results on May 5, 2025
GlobeNewswireApr 28 07:00 ET

Comments

Jerry Kronenberg

Mar 4 05:30

Columns Wall Street Today: Nasdaq Sheds 2%+, S&P 500 and DJIA Sink as Trump Confirms Canadian and Mexican Tariffs

Stocks tumbled Monday after President Trump confirmed plans to impose tariffs on Mexican and Canadian imports, sending the Nasdaq Composite down nearly 3% and the Dow industrials and S&P 500 off by some 1.5%.
The $Nasdaq Composite Index (.IXIC.US)$ shed 497.09 points (2.6%) to an 18,350.19 close, while the $S&P 500 Index (.SPX.US)$ sank 104.78 ticks (1.8%) to 5,849.72. The $Dow Jones Industrial Average (.DJI.US)$ likewise ...

Hot tech stocks pull back into the storm, a good opportunity to bottom or a risky trap?

Jerry Kronenberg

Mar 4 05:06

Columns Nasdaq Sheds 2%+, S&P 500 and DJIA Sink Some 1.5% as Trump Confirms Canadian and Mexican Tariffs

Stocks tumbled Monday after President Trump confirmed plans to impose tariffs on Mexican and Canadian imports, sending the Nasdaq Composite down nearly 3% and the Dow industrials and S&P 500 off by some 1.5%.
The $Nasdaq Composite Index (.IXIC.US)$ shed 497.09 points (2,6%) to a 18,350.19 close, while the $S&P 500 Index (.SPX.US)$ sank 104.78 ticks (1.8%) to 5,849.72. The $Dow Jones Industrial Average (.DJI.US)$ likewise ...

Hot tech stocks pull back into the storm, a good opportunity to bottom or a risky trap?

Teddy123

Mar 3 20:07

Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2024 Results and Business Highlights

$Ocular Therapeutix (OCUL.US)$
Can Ocular Therapeutix's $392M Cash Position Fuel Its AMD Treatment Through Approval?

Trytosaveabit

Aug 7, 2024 19:11

Update

$Ocular Therapeutix (OCUL.US)$ Ocular Therapeutix Has Received FDA Written Response That Phase 3 Sol-r Trial Is Appropriate For Use As The Company's Second Adequate And Well Controlled Study Of Axpaxli (Axitinib Intravitreal Implant, Also Known As OTX-TKI) For Wet Age-related Macular Degeneration

MARKET-TEST-DUMMY

Jun 16, 2024 03:49

This ticker got the gas?

$Ocular Therapeutix (OCUL.US)$